The level of deletion 17p and bi-allelic inactivation of TP53 has a significant impact on clinical outcome in multiple myeloma

• Sharmilan Thanendrarajan,
• Erming Tian,
• Pingping Qu,
• Pankaj Mathur,
• Carolina Schinke,
• Frits van Rhee,
• Maurizio Zangari,
• Leo Rasche,
• Niels Weinhold,
• Daisy Alapat,
• William Bellamy,
• Cody Ashby,
• Sandra Mattox,
• Joshua Epstein,
• Shmuel Yaccoby,
• Bart Barlogie,
• Antje Hoering,
• Michael Bauer,
• Brian A. Walker,
• Faith E. Davies,
• Gareth J. Morgan

Affiliations

Sharmilan Thanendrarajan

Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA

Erming Tian

Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA

Pingping Qu

Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA

Pankaj Mathur

Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA

Carolina Schinke

Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA

Frits van Rhee

Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA

Maurizio Zangari

Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA

Leo Rasche

Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA

Niels Weinhold

Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA

Daisy Alapat

Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, AR, USA

William Bellamy

Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, AR, USA

Cody Ashby

Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA

Sandra Mattox

Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA

Joshua Epstein

Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA

Shmuel Yaccoby

Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA

Bart Barlogie

Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA

Antje Hoering

Cancer Research and Biostatistics, Seattle, WA, USA

Michael Bauer

Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA

Brian A. Walker

Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA

Faith E. Davies

Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA

Gareth J. Morgan

Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA